SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-290709
Filing Date
2023-12-07
Accepted
2023-12-07 16:15:54
Documents
12
Period of Report
2023-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d555443d8k.htm   iXBRL 8-K 36048
  Complete submission text file 0001193125-23-290709.txt   155141

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bntc-20231206.xsd EX-101.SCH 2886
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20231206_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20231206_pre.xml EX-101.PRE 10836
6 EXTRACTED XBRL INSTANCE DOCUMENT d555443d8k_htm.xml XML 3212
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 231472567
SIC: 2834 Pharmaceutical Preparations